Literature DB >> 34977684

A simple and effective cryopreservation protocol for the industrially important and model organism, Euglena gracilis.

Mahfuzur R Shah1, Erin N Morrison1,2, Adam J Noble1, Scott C Farrow1,2.   

Abstract

Euglena gracilis is a source of high-value natural products. A major factor affecting consistent production of Euglena biomass is strain stability. Cryopreservation is a leading strategy for cell-line storage that helps ensure process reproducibility. We developed a simple cryopreservation protocol for heterotrophically cultured Euglena that enables the recovery of cells after 1 year with a cell viability of ≅80%. This protocol is suitable for labs interested in the long-term preservation of heterotrophic cultures of Euglena and related species.
© 2021 The Author(s).

Entities:  

Keywords:  Biotechnology and bioengineering; Cell Biology; Microbiology; Model Organisms

Mesh:

Year:  2021        PMID: 34977684      PMCID: PMC8686060          DOI: 10.1016/j.xpro.2021.101043

Source DB:  PubMed          Journal:  STAR Protoc        ISSN: 2666-1667


Before you begin

Development of the cryopreservation protocol

Consistent production of E. gracilis biomass is dependent on a preservation strategy that maintains the genetic fingerprint of the strain. Cryopreservation is a leading strategy for long-term cell-line storage that limits genetic drift, storage space, strain loss, cross-contamination, and permits facile clone transfer between facilities. Over the years, cryopreservation has been developed for a plethora of autotrophically grown microalgae and cyanobacteria, including Euglenophytes, by optimizing cryoprotectant solutions, freezing parameters, and recovery steps (Morris and Canning, 1978; Fleck et al., 2006; Day, 2007; Bui et al., 2013; Tessarolli et al., 2017; Kapoore et al., 2019). For example, Morris and Canning (1978) developed a method for E. gracilis but only achieved 30% cell recovery. We endeavored to improve upon such methods and create the first cryopreservation method for a commercial and heterotrophically grown strain of E. gracilis. By optimizing the cryoprotectant agent, freezing and thawing protocols and post recovery period, our cryoprotection protocol successfully preserves Euglena gracilis for at least 1 year with an enhanced cell recovery rate (≅ 80%) that permits faster process scaling.

E. gracilis acquisition and media preparation

Timing: Shipping + 1 day Obtain Euglena gracilis strain Z (UTEX 753; https://utex.org/products/utex-0753 Catalogue number: 0753). Prepare glucose supplemented growth media (i.e., modified E. gracilis media – MEGM, https://www.ccap.ac.uk/wp-content/uploads/MR_EG.pdf).

Preparation of cryopreservation equipment

Timing: 1 day Fill the Mr. Frosty cooling unit with 250 mL isopropanol and equilibrate overnight at 4°C. Pre-chill a cryo-box and cryo-rack (−196°C LN2) for long-term storage in LN2. Fill and prepare LN2 storage dewar. CRITICAL: Steps 3 and 4 should be done the day prior to cryopreservation.

Key resources table

Materials and equipment

Glucose Supplemented Growth Media (i.e., MEGM) ∗Add constituents above and make up to 1.0 L with deionized water. Growth medium should be sterilized by autoclaving at 15 psi, 121°C for 15 min or using a 0.2 μm filtration apparatus. We recommend MEGM but E. gracilis can also be grown in EG:JM media (https://www.ccap.ac.uk/wp-content/uploads/MR_EG_JM.pdf), Cramer-Myers media (Cramer and Myers, 1952), and Koren-Hutner media (Koren and Hutner, 1967).

Step-by-step method details

E. gracilis growth

Timing: 10–12 days This section describes the growth and culturing of E. gracilis cells from stock in preparation for harvesting. Unless otherwise indicated all culturing, harvesting and subsequent sections should be carried out under sterile conditions. Streak out fresh E. gracilis strain Z on glucose supplemented growth media + Agar (1.5%) using a sterile loop in a biosafety cabinet (or equivalent aseptic technique) and grow in the dark for 5–7 days (28°C) (Figures 1A–1C).
Figure 1

E. gracilis cell growth and monitoring

(A and B) E. gracilis cells grown on an agar slant (A) or plate (B) take on a pale-yellow appearance.

(C) Healthy colonies contain 10–90 round, pulsating cells (10× magnification, phase-contrast);

(D) Cells grown in 200 mL glucose supplemented growth media;

(E) Cell density determination (Countess II FL Automated cell counter);

(F) OD measurement (Spectrophotometer);

(G) Glucose measurement (YSI);

(H) Morphology monitoring of E. gracilis cells.

E. gracilis cell growth and monitoring (A and B) E. gracilis cells grown on an agar slant (A) or plate (B) take on a pale-yellow appearance. (C) Healthy colonies contain 10–90 round, pulsating cells (10× magnification, phase-contrast); (D) Cells grown in 200 mL glucose supplemented growth media; (E) Cell density determination (Countess II FL Automated cell counter); (F) OD measurement (Spectrophotometer); (G) Glucose measurement (YSI); (H) Morphology monitoring of E. gracilis cells. Inoculate 200 mL of fresh glucose supplemented growth media (Figure 1D) with E. gracilis cells (≅3.5 × 106 cells/mL) from step 1 using a sterile loop and grow heterotrophically in the dark (28°C, 120 rpm) until the glucose concentration is measured below 1 g/L (Figure 1G; ≅3 days). This equates to the late log or early stationary growth phase whereby cell count measures ≅ 12 × 106 cells/mL (Figure 1E) or at OD600 measures ≅ 4.8 (Figure 1F). Growth of cultures can be monitored using a spectrophotometer and/or a cell counter, and glucose can be monitored using a YSI Biochemistry Analyzer 2950 D or equivalent technique (Figure 1). We recommend monitoring cell morphology using a compound microscope equipped with a camera (Figure 1H).

Cell harvesting

Timing: 1–2 h This section describes the harvesting of cells for cryopreservation. Transfer 10 mL of the 200 mL culture to a 15 mL conical tube in a biosafety cabinet (or equivalent aseptic technique) using a 10 mL serological pipette. CRITICAL: 1 mL of sample should be used to assess cell viability. See: post-cryopreservation culturing and cell viability assaysstep 21. Pellet cells by centrifugation at 500 g for 5 min at 19°C–22°C (Figure 2A).
Figure 2

E. gracilis cell harvesting and incubation.

(A) Cell harvesting by centrifugation;

(B) Cell incubation for cell recovery.

E. gracilis cell harvesting and incubation. (A) Cell harvesting by centrifugation; (B) Cell incubation for cell recovery. After centrifugation, discard the supernatant and resuspend cells by gently pipetting in fresh, sterile glucose supplemented growth media to a final cell concentration of ≅ 10 × 106 cells/mL. Transfer the cell suspension to a sterile conical tube and let rest undisturbed at 19°C–22°C for a 30 min recovery period (Figure 2B). CRITICAL: 30 min cell recovery at 19°C–22°C is critical after centrifugation. Perform cryopreservation treatment according to the CPA treatment below.

Preparation of the cryoprotective agent (CPA)

Timing: 15 min These steps describe the preparation of the cryoprotectant agent under sterile conditions. Add 2 mL of reagent grade methanol (MeOH) to 8 mL of sterile glucose supplemented growth media to make 10 mL of 20% (v/v) cryoprotective agent (CPA). Filter-sterilize CPA into a 50 mL sterile conical tube using a 0.2 μm filter equipped with a 50 mL syringe (Figure 3) and keep at 19°C–22°C until use.
Figure 3

Preparation of CPA solution

Filter sterilization of CPA including glucose supplemented growth media.

Preparation of CPA solution Filter sterilization of CPA including glucose supplemented growth media. CRITICAL: CPA should be prepared fresh on the day of use. If CPA is stored for long periods or exposed to strong light, it can lose efficiency.

Treatment of cells with CPA

Timing: 30 min These steps describe the treatment of cells with CPA. Transfer 10 mL of E. gracilis cells (≅ 10 × 106 cells/mL) from step 6 into a universal glass vial and add 10 mL of CPA to make a final 20 mL solution containing 10% MeOH (v/v) (Figure 4).
Figure 4

Treatment of E. gracilis cells with CPA (MeOH) solution

Treatment of E. gracilis cells with CPA (MeOH) solution Seal vial(s) with parafilm and mix by gently inverting twice. You can customize the volume at step 10 if the ratio remains 1-CPA:1-cells (v/v). We make extra CPA in case of spillage or when additional aliquots are desired.

Transferring of cultures to cryovial and equilibration

Timing: 30 min This section describes the aliquoting of CPA treated cells. Aliquot 0.5 mL of CPA treated E. gracilis cells into sterile, 2.0 mL plastic screw cap vials. Repeat for a total of 18 vials - the capacity of the Mr. Frosty cooling container. Seal cryo-vials with parafilm and incubate for 15 min at 19°C–22°C (Figure 5).
Figure 5

E. gracilis cells transferred to cryo-vials and equilibration

E. gracilis cells transferred to cryo-vials and equilibration

Cooling and cryopreservation of E. gracilis cells

Timing: 2 h This section describes the transfer of CPA treated cells, the preparation protocol for use of the Mr. Frosty and long-term storage of Euglena cells. For cooling and cryopreservation of cells it is recommended to use the Mr. Frosty cooling device or a similar device like the Cool Cell™ which facilitate gradual cooling of cells. We tested an alternative cooling protocol by placing CPA treated cells directly at −80°C followed by LN2 but cells did not survive. Cooling Phase After incubation (step 13), immediately transfer cryo-vials containing CPA treated E. gracilis cells to the Mr. Frosty passive freezing system. CRITICAL: Step 14 should only proceed after the Mr. Frosty unit has been pre-treated with 250 mL of isopropanol and undergone overnight equilibration at 4°C. See: Before You Begin, step 3. Place the Mr. Frosty unit at -80°C and allow cells to rest for 1.5 h. The cooling rate during this step equates to −1 °C/min, and the temperature of the vial contents after 1.5 h is below −50°C (Figure 6).
Figure 6

Cooling of E. gracilis cells in Mr. Frosty placed in a −80°C freezer

(A) Cryovials organized in Mr. Frosty;

(B) Mr. Frosty inside a −80°C freezer.

Cryopreservation phase Take the pre-chilled cryopreservation vials containing the pre-chilled E. gracilis cells and quickly transfer them from the Mr. Frosty cooling unit into the pre-chilled (−196°C) cryo-box and cryo-rack for long term storage in LN2 (Figure 7).
Figure 7

Placement of cryo-vials in LN2 filled dewar

(A) Transferred cryo-vials from Mr. Frosty;

(B) Cryo-box transfer to cryo-rack;

(C) Cryo-rack to LN2 filled dewar;

(D) E. gracilis cells cryopreserved in LN2 filled dewar.

Monitor LN2 levels bi-weekly to ensure samples remain submerged in LN2. Pause point: Store cryopreserved cells for the desired time ensuring LN2 levels are maintained. CRITICAL: Ensure samples remain submerged in LN2 for the duration of storage. Cooling of E. gracilis cells in Mr. Frosty placed in a −80°C freezer (A) Cryovials organized in Mr. Frosty; (B) Mr. Frosty inside a −80°C freezer. Placement of cryo-vials in LN2 filled dewar (A) Transferred cryo-vials from Mr. Frosty; (B) Cryo-box transfer to cryo-rack; (C) Cryo-rack to LN2 filled dewar; (D) E. gracilis cells cryopreserved in LN2 filled dewar.

Thawing and recovery of E. gracilis cells after 1 year of cryopreservation

Timing: 1–2 h This section outlines the steps required for preparation of cryopreserved cells for reanimation. After the cryopreservation period (i.e., 1 year), remove the cryo-rack from LN2 and transfer the cryo-vials directly to a pre-warmed water bath (35°C, 1–2 min). CRITICAL: Immerse cryovials to cover vial contents. This step should be done carefully to avoid agitation, and vial contents should be left immersed until cells are completely thawed (1–2 min) (Figure 8). The optimal temperature for thawing is 35°C (check with an analog thermometer).
Figure 8

Thawing and recovery of E. gracilis cells after Cryopreservation

(A) Cryo-vials transferred from LN2 filled dewar for thawing;

(B) Thawing of cells in water bath;

(C) Centrifugation and washing of cells to remove CPA.

After thawing, immediately remove cryo-vials from the water bath and sterilize the outer surface with 70% (v/v) ethanol. Rapidly transfer vials to a class II biosafety cabinet. Thawing and recovery of E. gracilis cells after Cryopreservation (A) Cryo-vials transferred from LN2 filled dewar for thawing; (B) Thawing of cells in water bath; (C) Centrifugation and washing of cells to remove CPA. To increase osmolarity and the total volume to 1.0 mL, carefully add 0.5 mL of fresh glucose supplemented growth media to the cell suspension and mix by gently pipetting. Immediately pellet cells by gentle centrifugation (400 g for 3 min at 19°C–22°C) and discard the supernatant. Resuspend the pellet in 1 mL of fresh glucose supplemented growth media by gently pipetting, and incubate for 10 min at 19°C–22°C. Repeat step 19 once to remove remaining CPA. We have successfully recovered cells after 1 week, 3 months, 6 months and 1 year of cryopreservation.

Post-cryopreservation culturing and cell viability assays

Timing: 8–10 days This section outlines the cultivation and assessment of cell viability for cells that have been reanimated following cryopreservation and storage. As in previous sections steps should be carried out under sterile conditions. For culture vessels we recommend using T-25 flasks for post-cryopreservation culturing (step 20). T-25 flasks are advantageous as they can be placed directly under a microscope allowing for routine cell observation. Alternatively, one can use small, vented conical flasks but their use risks contamination as observing cells under the microscope requires opening the vessel to remove samples. Post-cryopreservation culturing Transfer 1 mL of washed E. gracilis cells to a culture vessel (T-25 flasks) containing 19 mL of fresh glucose supplemented growth media and grow cells on a rotary shaker at 80 rpm for 72–96 h at 28°C, under dark, heterotrophic conditions (Figure 9).
Figure 9

Post-cryopreservation culture and scale-up of E. gracilis culture

(A) E. gracilis cells transferred to T-25 flasks and grown inside a shaker incubator;

(B) Culture scale-up in 200 mL for further use.

CRITICAL: Take 1 mL of sample to assess cell viability. See: post-cryopreservation culturing and cell viability assays, step 21. After 72–96 h of growth (cell count ≅ 4.5 × 106 cells/mL), transfer 20 mL of culture to 200 mL of fresh glucose supplemented growth media in a 1 L conical flask. Continue to grow culture under the same conditions but with a modified rotation speed, which should be changed to 120 rpm (Figure 9). Monitor cell density (cells/mL) and optical density (OD600) during post-cryopreservation culturing. Make morphological observations using a microscope to determine the health and viability of the culture (Figure 1). Cell Viability Assays To evaluate cryopreservation success, if resources permit, we recommend testing the success of the cryopreservation protocol at different time intervals (i.e., bi-weekly, monthly, quarterly, yearly) using the indicated cell viability assay. The viability of E. gracilis cells should be assessed using Trypan Blue (TB) and microscopy. This is done three times: (1) Before cryopreservation (step 3 of cell harvesting), (2) immediately after thawing (step 20a) and (3) immediately after the post-cryopreservation culturing period (step 20b). TB stains dead E. gracilis cells, which acquire a dark blue appearance. Living (viable) cells maintain their natural color. The following outlines the TB staining procedure (Figure 10).
Figure 10

Cell viability assay using Trypan Blue

(A) Before Cryopreservation (60×; 50 μm scale bar);

(B) Before Cryopreservation (20×; 200 μm scale bar);

(C) Immediately after thawing (20×; 200 μm scale bar);

(D) Post cryopreserved and recovered culture (20×; 200 μm scale bar). Dark-blue cells are considered dead/inactive cells; Non stained cells are considered living/active cells.

When working with Trypan Blue follow all safety protocols as indicated by the manufacturer, wear appropriate PPE and discard waste in appropriate vessels. Add 1 mL of E. gracilis cell culture to a 2 mL tube and centrifuge at 2400 g for 5 min at 19°C–22°C and discard the supernatant. Add 1 mL of 0.4% TB solution to the cell pellet, mix by gently pipetting, and incubate at 19°C–22°C for 10 min. After incubation, centrifuge the sample at 2400 g for 5 min at 19°C–22°C, remove 900 μL of supernatant and replace with 900 μL of distilled water. Mix sample gently by pipetting and centrifuge at 2400 g for 5 min at 19°C–22°C to remove supernatant. Resuspend cells in 1 mL of distilled water and repeat the washing step three times. A minimum of 50 cells should be counted under the microscope (or microscope photo) to calculate viable and dead E. gracilis cells (Figure 1). Cell viability (%) is calculated using the following formula: (number of living cells/ number of total cells) × 100%. To avoid underestimating cell viability due to the presence of dead cells in the original cultures (step 3, cell harvesting), the viability of initial cultures should be calculated for comparison. Post-cryopreservation culture and scale-up of E. gracilis culture (A) E. gracilis cells transferred to T-25 flasks and grown inside a shaker incubator; (B) Culture scale-up in 200 mL for further use. Cell viability assay using Trypan Blue (A) Before Cryopreservation (60×; 50 μm scale bar); (B) Before Cryopreservation (20×; 200 μm scale bar); (C) Immediately after thawing (20×; 200 μm scale bar); (D) Post cryopreserved and recovered culture (20×; 200 μm scale bar). Dark-blue cells are considered dead/inactive cells; Non stained cells are considered living/active cells.

Expected outcomes

The developed cryopreservation protocol is a simple and straightforward protocol for the long-term maintenance, storage, and recovery of heterotrophically grown E. gracilis strain Z. This protocol allows for long-term genetic stability and a storage strategy for companies and academic labs interested in E. gracilis. Additionally, it allows for easy strain recovery, transfer between locations and provides a useful starting point for developing subsequent methods for the maintenance and storage of other Euglena strains and species.

Limitations

This protocol is dependent on the health of the starting cell culture, and adherence to the steps outlined above. This method has been optimized for heterotrophically cultured Euglena gracilis strain Z but serves as a starting point for Euglena grown using alternative carbon sources, and other Euglena strains and species.

Troubleshooting

Problem 1

Growth kinetics are slowed or there is a reduced culture growth rate (step 1).

Potential solution

E. gracilis can grow over a wide temperature range (22°C–30°C) but we recommend growing E. gracilis cells at the experimentally optimized growth temperature (28°C). If slower growth rates are observed, it is recommended to check that all growing conditions are consistent with our suggested parameters. Sub-optimal growth can also be a consequence of an unhealthy culture, and therefore its health should be assessed before proceeding with cryopreservation. Healthy E. gracilis cells in liquid culture are elongated and actively moving. If they are rounded or non-motile, cultures should not be used for cryopreservation.

Problem 2

Cryopreserved cells did not successfully reanimate indicating unsuccessful cryopreservation (step 8). CPA is a critical solution and should be prepared before harvesting cells for cryopreservation. Cryopreservation efficiency drops with CPA that has been stored for extended time frames or when it is exposed to light. It is not recommended to store CPA at 4°C or −20°C as this can also reduce efficiency. In addition, CPA must be mixed with growth media (1v:1v). It cannot be used with water. We have tested alternative CPA solutions (e.g., glycerol, DMSO) and concentrations and found that the final concentration of 10% MeOH is optimal for heterotrophically grown E. gracilis.

Problem 3

Unsuccessful cell recovery (step 16). Unlike common laboratory organisms (i.e., yeast), E. gracilis does not have a cell wall which makes it sensitive to abrupt temperature changes. As such, the temperature and timing parameters described in this protocol must be strictly adhered to. For example, transfer of cells from LN2 to the water bath should be done quickly, as extended times at RT will impact recovery. We also tested different recovery temperatures (i.e., 28°C, 35°C and 37°C) and intervals (1, 2, and 3 min) but 35°C and 1–2 min was optimal. If viability remains poor, one must ensure that cells are healthy before harvesting, and that cells are not damaged during resuspension. Again, we recommend using the cell viability assay at the indicated steps before cryopreservation to assist with the evaluation of cell health.

Problem 4

Contaminated cultures (step 2). All transferring steps must be carried out aseptically in a class II biosafety cabinet. While a biosafety cabinet is recommended, a laminar flow-hood and/or flame can be used to maintain dead airspace. All equipment, tubes etc. should be sterile prior to use and good aseptic technique should be used throughout.

Resource availability

Lead contact

Further information and requests for resources and reagents should be directed to and will be fulfilled by the lead contact, Scott Farrow (scott.c.farrow@gmail.com).

Materials availability

This study did not generate new unique reagents.
REAGENT or RESOURCESOURCEIDENTIFIER
Chemicals, peptides, and recombinant proteins

MethanolFisher ScientificCAT # 67-56-1
Sodium acetate trihydrateFisher ScientificCAT # AC123240000
Lab-Lemco powderThermo Fisher ScientificCAT # LP0029B
TryptoneThermo Fisher ScientificCAT # 211701
Yeast extractThermo Fisher ScientificCAT # 212750
Calcium ChlorideFisher ScientificCAT # AC219170000
GlucoseThermo Fisher ScientificCAT # 15023021
Trypan Blue (0.4%) solutionThermo Fisher ScientificCAT # 15250061
70% EthanolFisher ScientificCAT # BP82031GAL

Experimental models: Organisms/strains

Euglena gracilis strain ZUTEXUTEX 753

Other

Mr. Frosty Passive freezing unitNalgene Nunc InternationalCAT # 5100-0001
Syringe filters (0.2 μm)BasixCAT # 13100106
1 L Erlenmeyer flasks, vented cap, PolycarbonateCorningCAT # 431147
Sterile syringes (60 mL)Air-TiteCAT # MS60
Serological pipettes (10 mL)FroggaBioCAT # SP 10-200
Cryo-vials (pre sterilized plastic screw cap, 2 mL)CorningCAT # 430659
Glass Universal Vials (20 mL)Thermo Fisher ScientificCAT #139-20ACT
Countess II FL Automated cell counterThermo Fisher ScientificCAT # AMQAF1000
T-25 flasksFisher ScientificCAT # 12-565-348
YSI Biochemistry Analyzer 2950 DYSI Life ScienceCAT # 527690
Polycarbonate storage boxesNalgeneCAT # 5026-1010
Nalgene 0.2 μm Filter UnitNalgeneCAT # 566-0020
Locator JR Plus Rack and Box Cryo System Nitrogen Storage DewarThermo ScientificCAT # CY50985
Long forceps (19 cm)Fisher ScientificCAT # 50-822-717
Compound Microscope with Camera: EVOS FL AUTO AMAFD 1000Life TechnologiesSN # 1313-178C-098
Shaking Incubator with Temperature Control, ISF-4-VAdolf Kohner AGISN # 88703-6
Heated water-bath, ISOTEMP 205Fisher ScientificCAT # 15-462-5
Benchtop Microcentrifuge, Sorvall Legend Micro 21Thermo ScientificCAT # 5002436
Benchtop Centrifuge, Sorvall ST 16Thermo ScientificCAT # 75004241
–80°C freezerForma ScientificSN # 21094-2777
Spectrophotometer, SpectraMax - M3 Multi mode microplate readerMolecular DevicesCAT # M3
PPE: lab coat, cryo-gloves, cryo-apron, protective gogglesN/AN/A
Class II Biological Safety Cabinet, 1284 REL-3Thermo FormaSN # 45346

Glucose Supplemented Growth Media (i.e., MEGM)

ReagentFinal concentrationAmount
Sodium acetate trihydrate1 g/L1.0 g
Lab-Lemco powder1 g/L1.0 g
Tryptone2 g/L2.0 g
Yeast extract2 g/L2.0 g
Calcium chloride1 g/L1.0 g
Glucose15 g/L15.0 g

∗Add constituents above and make up to 1.0 L with deionized water. Growth medium should be sterilized by autoclaving at 15 psi, 121°C for 15 min or using a 0.2 μm filtration apparatus.

  4 in total

1.  Characterisation of cryoinjury in Euglena gracilis using flow-cytometry and cryomicroscopy.

Authors:  Roland A Fleck; Roger W Pickup; John G Day; Erica E Benson
Journal:  Cryobiology       Date:  2006-02-07       Impact factor: 2.487

Review 2.  Cryopreservation of microalgae and cyanobacteria.

Authors:  John G Day
Journal:  Methods Mol Biol       Date:  2007

3.  Effects of cryopreservation on viability and functional stability of an industrially relevant alga.

Authors:  Rahul Vijay Kapoore; María Huete-Ortega; John G Day; Katarzyna Okurowska; Stephen P Slocombe; Michele S Stanley; Seetharaman Vaidyanathan
Journal:  Sci Rep       Date:  2019-02-14       Impact factor: 4.379

4.  Impact of procedural steps and cryopreservation agents in the cryopreservation of chlorophyte microalgae.

Authors:  Tony V L Bui; Ian L Ross; Gisela Jakob; Ben Hankamer
Journal:  PLoS One       Date:  2013-11-11       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.